Understanding the risks and benefits of opioid substitution treatment in Europe:
triangulating data from monitoring and research sources
Reitox sponsored session
Thursday, 24 September 2015, 12.45–14.15, Room 3
Chaired by Alessandro Pirona, EMCDDA
Introduction by the Chair
Opioid substitution treatment and methadone-related deaths in Ireland — Suzi Lyons, Senior
Researcher, Health Research Board, Dublin (Ireland)
Risks and benefits of opioid substitution treatment in Austria — Marion Weigl, Head of the Austrian
Reitox focal point, Austrian Public Health Institute, Gesundheit Österreich
Strong and weak points of opioid substitution treatment in the Czech Republic — Viktor Mravčík,
Head of the National Monitoring Centre for Drugs and Addiction, Office of the Government of the
Czech Republic
Assessing 20 years of opioid substitution treatment in France — Anne-Claire Brisacier, Head of
studies, French monitoring centre for drugs and drug addiction
Debate and conclusions
Free lunch boxes will be provided to all attendees